<DOC>
	<DOCNO>NCT00569400</DOCNO>
	<brief_summary>This trial conduct Asia Oceania . The aim trial compare efficacy safety human insulin produce current process NN729 process type 1 diabetes .</brief_summary>
	<brief_title>Comparison Human Insulin Produced Current Process NN729 Process Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Duration diabetes least 12 month Basal/bolus treatment human insulin least 2 month precede trial start Body Mass Index ( BMI ) lesser equal 35.0 kg/m2 HbA1c lesser equal 12.0 % Proliferative retinopathy maculopathy require acute treatment laser treatment within last 6 month Any condition investigator and/or sponsor feel would interfere trial participation Known suspect allergy trial product relate product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>